|
Follow the links below to find information on post market monitoring of the safety of drugs.
Created Sept 2007
Printer friendly page
| Results 1 to 8 displayed. |
| Title: |
Safety alerts and advisory statements
|
| Publisher: |
Australian Government Department of Health and Ageing
|
| Description: |
Links to safety alerts and advisory statements about medicines and medical devices in Australia.
|
| Date: |
Aug 2008
|
| Title: |
Zolpidem ("Stilnox") - updated information - February 2008
|
| Publisher: |
Australian Government Department of Health and Ageing
|
| Description: |
As a response to these observed adverse effects, significant changes have been made to the Product Information (PI) and Consumer Medicine Information (CMI) documents for products containing zolpidem.
|
| Date: |
Feb 2008
|
| Title: |
Dental notes - reporting adverse reactions
|
| Publisher: |
Australian Prescriber
|
| Description: |
Dentists may well be in a unique position to be able to assess potential adverse reactions to the medication that we prescribe and that prescribed by our medical colleagues.
|
| Date: |
Dec 2005
|
| Title: |
Comments for consumers - reporting adverse reactions
|
| Publisher: |
Australian Prescriber
|
| Description: |
To increase information about medicines' safety, health professionals report side effects to the Adverse Drug Reactions Unit of the Therapeutic Goods Administration. These reports are assessed to see if problems are emerging. In some cases medicines have been restricted for use, or banned for safety reasons.
|
| Date: |
Dec 2005
|
| Title: |
Showing the blue card: reporting adverse reactions
|
| Publisher: |
Australian Prescriber
|
| Description: |
Reports of suspected adverse drug reactions are sent to the Adverse Drug Reactions Unit of the Therapeutic Goods Administration. Selected reports are forwarded to the Adverse Drug Reactions Advisory Committee which can recommend actions ranging from no action to the withdrawal of a drug from the market.
|
| Date: |
Dec 2005
|
| Title: |
Australian pharmacovigilance guideline
|
| Publisher: |
Australian Government Department of Health and Ageing
|
| Description: |
The Australian Guideline for Pharmacovigilance Responsibilities of Sponsors of Registered Medicines Regulated by Drug Safety and Evaluation Branch (July 2003) has been amended to reflect changes that have occurred to EU pharmacovigilance reporting documentation.
|
| Date: |
May 2005
|
| Title: |
TGA Office of Laboratories and Scientific Services
|
| Publisher: |
Australian Government Department of Health and Ageing
|
| Description: |
Information on the role, organisation, and activities of the TGA Office of Laboratories and Scientific Services.
|
| Date: |
Jun 2003
|
| Results 1 to 8 displayed. |
|